UK Committee Wants Compulsory Licensing To Secure Cheap COVID-19 Products
ABPI Says Suggestion Is ‘Disappointing’
Executive Summary
Some way needs to be found to guarantee the supply of coronavirus products as more of them begin to become available, but the pharmaceutical industry says compulsory licensing is not the answer.